Louisiana Fund

Qure4u is an all-in-one patient experience platform that offers a fully integrated solution that supports the entire patient journey. It drives brand equity, in-office efficiency, and revenue while enhancing clinical insight and improving the patient experience. It also empowers patients to prepare for appointments, monitor their vitals, and connect with their providers via secure messaging and telehealth through Qure4u's all-in-one app. It was founded in 2011 and is headquartered in Bradenton, Florida.

Omnidek is an enterprise smart data content management platform that enables businesses of various sizes to create corporate forms, portals, workflows, and analytics within a unified mobile and web interface. The platform streamlines business operations by eliminating the need for paper, files, folders, and spreadsheets, thereby enhancing efficiency. Omnidek incorporates a chat-style inbox that facilitates integrated workflows, simplifying communication and collaboration among teams. By consolidating third-party applications, the platform supports organizations in deploying technology more effectively, allowing for data-driven decision-making and improved business process management.

Servato Corp. specializes in active battery management solutions designed for various industrial applications, including telecom, data centers, and utilities. The company provides an Active Battery Management System, which efficiently manages, charges, and monitors lead-acid batteries used for backup power. Additionally, Servato offers the Smart Power System-148, a remote management device that automates the monitoring and management of standby batteries. Through its analytics-driven software, ActiView, users can access real-time insights into the health of batteries at multiple sites, enhancing operational efficiency. Founded in 2014 and headquartered in New Orleans, Louisiana, Servato aims to ensure reliable power management and continuity in critical infrastructure.

Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Esperance Pharmaceuticals Inc. develops targeted anticancer drugs to treat women with ovarian and breast cancer. Its products include EP-100, an oncolytic peptide that seeks and destroys cancer cells that express receptors for luteinizing hormone releasing hormone (LHRH), and selectively kill cancer cells without harming normal cells. The company has strategic alliance with MD Anderson Cancer Center to accelerate clinical development of EP-100 for the treatment of women with ovarian cancer and breast cancer. Esperance Pharmaceuticals Inc. was incorporated in 2005 and is based in Houston, Texas.

Esperance Pharmaceuticals Inc. develops targeted anticancer drugs to treat women with ovarian and breast cancer. Its products include EP-100, an oncolytic peptide that seeks and destroys cancer cells that express receptors for luteinizing hormone releasing hormone (LHRH), and selectively kill cancer cells without harming normal cells. The company has strategic alliance with MD Anderson Cancer Center to accelerate clinical development of EP-100 for the treatment of women with ovarian cancer and breast cancer. Esperance Pharmaceuticals Inc. was incorporated in 2005 and is based in Houston, Texas.

At Portico, they have focused on providing eLearning solutions to government and corporate entities since 1998. They specialize in courseware management and custom eLearning courseware development, and have implemented both their courseware and their learning management systems successfully in a wide range of technical environments. Their company currently provides eLearning to many companies spanning many industries, worldwide. Their approach to every solution is to match training initiatives to their clients' business objectives and strategies, enabling them to add value to their enterprise.

Flying Fish Creative Services Inc., a Baton Rouge, La.-based provider of e-learning training programs focused on courseware management.